Active ingredientFenfluramineCat. No. P-F022-001CAS 458-24-2Family · Pharmaceutical analytical standards
Fenfluramine
An amphetamine derivative that releases serotonin, introduced in France in 1963 as an appetite suppressant; since 2020 it has been approved in the United States and Europe for seizures in Dravet syndrome and later in Lennox-Gastaut syndrome. This family brings together the active ingredient, nitrosamines and other impurities.
Did you know?Dravet syndrome is named after the French child psychiatrist and epileptologist Charlotte Dravet, who described it in 1978 in Marseille.
Go to the active ingredient →Active ingredientFenfluramineCat. No. P-F022-001CAS 458-24-2
Active ingredientFenfluramine HClCat. No. P-F022-002CAS 404-82-0
NitrosamineN-NitrosofenfluramineCat. No. P-F022-004CAS 19023-40-6
ImpurityFenfluramine Impurity 1Cat. No. P-F022-005CAS 21235-67-6
ImpurityFenfluramine Impurity 2Cat. No. P-F022-006CAS 21906-39-8
ImpurityFenfluramine Impurity 3Cat. No. P-F022-007CAS 713-45-1
ImpurityFenfluramine Impurity 4Cat. No. P-F022-008CAS 52777-74-9
ImpurityFenfluramine Alcohol ImpurityCat. No. P-F022-009CAS 621-45-4
ImpurityFenfluramine Benzylethamine HCl ImpurityCat. No. P-F022-010CAS 90388-99-1
ImpurityFenfluthrinCat. No. P-F022-011CAS 75867-00-4
ImpurityFenfluramine Impurity 5 HydrochlorideCat. No. P-F022-012CAS 54779-55-4
ImpurityNorfenfluramine HClCat. No. P-F022-013CAS 673-18-7
ImpurityR-FenfluramineCat. No. P-F022-014CAS 37577-24-5
ImpurityR-NorfenfluramineCat. No. P-F022-015CAS 37577-22-3
ImpurityS-FenfluramineCat. No. P-F022-016CAS 3239-44-9
ImpurityS-NorfenfluramineCat. No. P-F022-017CAS 19036-73-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.